|
|
| | AVENANTHRAMIDEC Basic information |
| Product Name: | AVENANTHRAMIDEC | | Synonyms: | AVENANTHRAMIDEC;N-[3′,4′-Dihydroxy-(E)-cinnamoyl]-5-hydroxyanthranilic acid;2-{[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]amino}-5-hydroxybenzoic acid;Avenanthramide Bc;Benzoic acid, 2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]amino]-5-hydroxy-;(E)-2-(3-(3,4-Dihydroxyphenyl)acrylamido)-5-hydroxybenzoic acid | | CAS: | 116764-15-9 | | MF: | C16H13NO6 | | MW: | 315.28 | | EINECS: | | | Product Categories: | | | Mol File: | 116764-15-9.mol |  |
| | AVENANTHRAMIDEC Chemical Properties |
| Melting point | 248-250°C (dec.) | | Boiling point | 702.3±60.0 °C(Predicted) | | density | 1.582±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | Methanol (Slightly, Heated) | | pka | 3.37±0.36(Predicted) | | color | Pale Yellow to Light Yellow | | BRN | 3624543 |
| Hazard Codes | Xn | | Risk Statements | 22 | | WGK Germany | 3 |
| | AVENANTHRAMIDEC Usage And Synthesis |
| Uses | Avenanthramide C is an antioxidant and an anti-inflammatory agent. Avenanthramide reduces and attenuates proliferation of colonic cancer cells. Avenanthramide C inhibits chymotrypsin activity and moderately trypsin activity. | | Definition | ChEBI: 2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid is an alkaloid and a member of benzamides. |
| | AVENANTHRAMIDEC Preparation Products And Raw materials |
|